351 related articles for article (PubMed ID: 23401272)
1. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension.
Landsberg L; Aronne LJ; Beilin LJ; Burke V; Igel LI; Lloyd-Jones D; Sowers J
Obesity (Silver Spring); 2013 Jan; 21(1):8-24. PubMed ID: 23401272
[TBL] [Abstract][Full Text] [Related]
2. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.
Landsberg L; Aronne LJ; Beilin LJ; Burke V; Igel LI; Lloyd-Jones D; Sowers J
J Clin Hypertens (Greenwich); 2013 Jan; 15(1):14-33. PubMed ID: 23282121
[TBL] [Abstract][Full Text] [Related]
3. Challenges and strategies in managing cardiometabolic risk.
Repas TB
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
[TBL] [Abstract][Full Text] [Related]
4. Obesity and metabolic syndrome as related to cardiovascular disease.
Nikolopoulou A; Kadoglou NP
Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):933-9. PubMed ID: 22908926
[TBL] [Abstract][Full Text] [Related]
5. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.
Jordan J; Yumuk V; Schlaich M; Nilsson PM; Zahorska-Markiewicz B; Grassi G; Schmieder RE; Engeli S; Finer N
J Hypertens; 2012 Jun; 30(6):1047-55. PubMed ID: 22573071
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of patients with high cardiovascular risk in general practice].
Ilyés I; Erdei I; Jancsó Z
Orv Hetil; 2004 Aug; 145(33):1723-6. PubMed ID: 15462478
[No Abstract] [Full Text] [Related]
8. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
9. [Treatment for hypertension with metabolic disorders (DM etc)].
Shimamoto K; Miura T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
[No Abstract] [Full Text] [Related]
10. Diagnosis and management of hypertension in obesity.
Narkiewicz K
Obes Rev; 2006 May; 7(2):155-62. PubMed ID: 16629872
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach.
Ganne S; Arora S; Karam J; McFarlane SI
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):201-11. PubMed ID: 17338665
[TBL] [Abstract][Full Text] [Related]
12. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management.
Kotchen TA
Am J Hypertens; 2010 Nov; 23(11):1170-8. PubMed ID: 20706196
[TBL] [Abstract][Full Text] [Related]
13. [Obesity and hypertension: from physiopathology to treatment].
Geronooz I; Krzesinski JM
Rev Med Liege; 2000 Oct; 55(10):921-8. PubMed ID: 11244800
[TBL] [Abstract][Full Text] [Related]
14. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
[TBL] [Abstract][Full Text] [Related]
15. European Society of Hypertension Working Group on Obesity: background, aims and perspectives.
Jordan J; Engeli S; Redon J; Sharma AM; Luft FC; Narkiewicz K; Grassi G;
J Hypertens; 2007 Apr; 25(4):897-900. PubMed ID: 17351387
[No Abstract] [Full Text] [Related]
16. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
[No Abstract] [Full Text] [Related]
17. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in obesity.
Redon J
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
[TBL] [Abstract][Full Text] [Related]
19. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
20. The obesity epidemic and its impact on hypertension.
Nguyen T; Lau DC
Can J Cardiol; 2012 May; 28(3):326-33. PubMed ID: 22595448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
